Vinod Jaskula-Ranga
Founder, President, and CEO, Hunterian Medicine
Vinod Jaskula-Ranga is the founder, president, and CEO of Hunterian Medicine, a pre-clinical biotech company focused on CRISPR gene-editing technologies. He is the lead inventor on over 75 pending US and international patents, including a CRISPR and AAV therapeutic-delivery technology. Jaskula-Ranga’s research has been highlighted by Chemical & Engineering News, Genetic Engineering & Biotechnology News, Biotechniques, Xconomy, and GenomeWeb, among others. Prior to starting Hunterian Medicine, he completed a fellowship in genetic engineering and molecular ophthalmology at the Wilmer Eye Institute of the Johns Hopkins University School of Medicine, where he received his doctorate in molecular biology and genetics and trained in the laboratory of Nobel Prize laureate Carol Greider.
Previously
Six decades after the discovery of the DNA double helix, basic gene sequencing is becoming increasingly accessible to consumers, and start-up companies are hurtling into the r...
Dan Porterfield, Margaret Low, and Peggy Clark kick off Aspen Ideas: Health. This session also features Big Ideas from Health presenters.